Small-nucleolar RNA host gene3 (SNHG3) and leukemia-associated non-coding IGF1R activator RNA 1 (LUNAR1) correlated

Omnia Emam1, Eman F Wasfey2, Mostafa Elnakib3,4

  • 1Egyptian Drug Authority, Cairo, Egypt.

Scientific Reports
|February 26, 2026
PubMed

Insights

Circulating Notch-associated long non-coding RNAs (lncRNAs), SNHG3 and LUNAR1, are elevated in colorectal cancer (CRC) patients. These lncRNAs show potential as non-invasive biomarkers for CRC monitoring and risk assessment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Notch-signaling is involved in tumorigenesis.
  • Notch-associated long non-coding RNAs (lncRNAs), SNHG3 and LUNAR1, are upregulated in various cancers, including colorectal cancer (CRC).
  • The clinical and prognostic value of these circulatory lncRNAs in CRC remains underexplored.

Purpose of the Study:

  • To assess the expression patterns of circulatory SNHG3 and LUNAR1 in CRC patients.
  • To investigate the relevance of these lncRNAs for CRC follow-up and risk stratification.
  • To evaluate their potential as non-invasive biomarkers for CRC.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to measure SNHG3 and LUNAR1 expression levels.
  • Serum samples from 70 Egyptian CRC patients and 26 healthy controls were analyzed.
  • Statistical analyses were performed to compare expression levels and correlate them with clinicopathological features.

Main Results:

  • Serum SNHG3 and LUNAR1 were significantly upregulated in CRC patients compared to controls (p < 0.0001).
  • SNHG3 expression correlated positively with advanced CRC stage, tumor invasion, vascular invasion, and lymph node metastasis.
  • LUNAR1 expression was associated with larger tumor size and deeper invasion. Both lncRNAs demonstrated higher diagnostic accuracy than CEA and CA19-9.

Conclusions:

  • Circulatory SNHG3 and LUNAR1 serve as promising non-invasive biomarkers for CRC monitoring.
  • These lncRNAs correlate with adverse clinicopathological features, suggesting their potential as prognostic indicators.
  • SNHG3 and LUNAR1 may represent novel therapeutic targets for CRC, paving the way for ncRNA-based precision medicine.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K